๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Compound trial record
Trackers Drugs Trial finder
Compound · clinical trials

Control group

Source: ClinicalTrials.gov, U.S. National Library of Medicine — the 12 trials in our China and USA registers that name Control group as an intervention. Synced 25 Sep 2026
12Trials tracked
7Recruiting now
10Lead sponsors
2Country registers
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 โ€” Top 14 finalist
Compiled from ClinicalTrials.gov registry records ยท Last verified ยท Editorial standards

Control group is named as a drug or biological intervention in 12 clinical trials in our China and USA trial registers, 7 of which are recruiting. Lead sponsors include Beijing Tiantan Hospital (3), Research Insight LLC (1) and Anhui Provincial Hospital (1). Registered phases: Not applicable, Phase 4, Phase 2/3, Phase 2, Phase EARLY_PHASE1, Phase 1/2 and Phase 1. Conditions studied include Post Cataract Surgery; Hepatocellular Carcinoma (HCC); Liver Diseases.

01

Clinical trials of Control group

12 trials
NCT IDStudyPhaseStatusLead sponsorRegister
NCT07662655 Percutaneous Pulmonary Artery Denervation (PADN) for the Treatment of Pulmonary Hypertension After Transcatheter Mitral Valve Edge-to-Edge Repair (M-TEER): A Prospective Cohort Study (ClinicalTrials.gov ↗)
Pulmonary Hypertension, Pulmonary Hypertension Associated With HFpEF
Phase EARLY_PHASE1 Recruiting Xiamen Cardiovascular Hospital, Xiamen University China
NCT07150624 The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine (ClinicalTrials.gov ↗)
Hepatocellular Carcinoma (HCC), Liver Diseases
Phase 4 Recruiting Anhui Provincial Hospital China
NCT07505472 Efficacy and Safety Comparison of Short-course Radiotherapy Followed by CapeOX Chemotherapy Plus Toripalimab With or Without Concurrent Surufatinib in Neoadjuvant Therapy for Mid-to-low Localized Rectal Cancer of High-risk Criteria (ClinicalTrials.gov ↗)
Rectal Cancer
Phase 2/3 Recruiting The First Hospital of Jilin University China
NCT05532943 Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis (ClinicalTrials.gov ↗)
Multiple Sclerosis
Phase 1/2 Recruiting Ever Supreme Bio Technology Co., Ltd. China
NCT07169214 Evaluation of Safety, Efficacy, and Pharmacokinetics of BT-114143 Injection in Patients With Abnormal Uterine Bleeding (ClinicalTrials.gov ↗)
Abnormal Uterine Bleeding
Phase 1 Recruiting ScinnoHub Pharmaceutical Co., Ltd. China
NCT06896994 Esketamine Combined Pregabalin and Duloxetine for Postherpetic Neuralgia (ClinicalTrials.gov ↗)
Postherpetic Neuralgia
Not applicable Recruiting Beijing Tiantan Hospital China
NCT07422506 A Real-World Study Comparing the Efficacy of Different Treatment Regimens for Early Missed Abortion (ClinicalTrials.gov ↗)
Missed Abortion, Early Pregnancy Failure
Not applicable Recruiting The Third Xiangya Hospital of Central South University China
NCT07276802 The TRIBECA Study (TRIessence/Byqlovi for Easier CAtaract Surgery) (ClinicalTrials.gov ↗)
Post Cataract Surgery
Phase 4 Not yet open Research Insight LLC USA
NCT07801183 Efficacy and Safety of Anrikefon Injection for Multimodal Postoperative Analgesia in Patients Undergoing Laparoscopic Hepatectomy (ClinicalTrials.gov ↗)
Postoperative Acute Pain
Phase 4 Not yet open Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University China
NCT06772233 A Study of Regorafenib Combined With Envafolimab for Metastatic Gastrointestinal Stromal Tumors With Kit Gene Exon 17 Mutation That Failed Standard Treatment (ClinicalTrials.gov ↗)
Metastatic Gastrointestinal Stromal Tumors (GIST)
Phase 2 Not yet open Peking University China
NCT06914180 Esketamine Combined With PRF for Trigeminal Postherpetic Neuralgia (ClinicalTrials.gov ↗)
Postherpetic; Neuralgia, Trigeminal (Etiology)
Not applicable Not yet open Beijing Tiantan Hospital China
NCT07737158 Venlafaxine for Non-specific Low Back Pain (ClinicalTrials.gov ↗)
Non-specific Low Back Pain, Pain Management
Not applicable Not yet open Beijing Tiantan Hospital China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.

02

Conditions studied

16 conditions
Condition (as registered)Trials
Post Cataract Surgery1
Hepatocellular Carcinoma (HCC)1
Liver Diseases1
Rectal Cancer1
Missed Abortion1
Early Pregnancy Failure1
Non-specific Low Back Pain1
Pain Management1
Postoperative Acute Pain1
Postherpetic Neuralgia1
Metastatic Gastrointestinal Stromal Tumors (GIST)1
Pulmonary Hypertension1
Pulmonary Hypertension Associated With HFpEF1
Postherpetic; Neuralgia, Trigeminal (Etiology)1
Multiple Sclerosis1
Abnormal Uterine Bleeding1
03

Sponsors

lead sponsor per trial
Lead sponsorTrials
Beijing Tiantan Hospital3
Research Insight LLC1
Anhui Provincial Hospital1
The First Hospital of Jilin University1
The Third Xiangya Hospital of Central South University1
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University1
Peking University1
Xiamen Cardiovascular Hospital, Xiamen University1
Ever Supreme Bio Technology Co., Ltd.1
ScinnoHub Pharmaceutical Co., Ltd.1
04

Trials by country register

RegisterControl group trials
Clinical trials in China11
Clinical trials in USA1

A trial with sites in more than one country appears in each of those registers.

How this page is built

Everything on this page is copied from public ClinicalTrials.gov registry records โ€” it is not written from memory, and nothing here describes how Control group works or whether it is effective. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Control group (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 25 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician โ€” our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us โ€” we correct promptly and log it.